Cargando…
An update of advanced nanoplatforms for Glioblastoma Multiforme Management
Glioblastoma multiforme (GBM) is a very aggressive and heterogeneous glioma. Currently, GBM is treated with a combination of surgery, radiotherapy, chemotherapy (e.g. temozolamide) and Tumour Treating Fields. Unfortunately, the mean survival is still around 15 months. This poor prognosis is associat...
Autores principales: | Amaral, Mariana, Cruz, Nuno, Rosa, Ana, Nogueira, Beatriz, Costa, Diana, Santos, Francisco, Brazão, Mariana, Policarpo, Pedro, Mateus, Rita, Kobozev, Yan, Reis, Catarina Pinto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Leibniz Research Centre for Working Environment and Human Factors
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678060/ https://www.ncbi.nlm.nih.gov/pubmed/34924904 http://dx.doi.org/10.17179/excli2021-4393 |
Ejemplares similares
-
An Update in the Use of Antibodies to Treat Glioblastoma Multiforme
por: Hernández-Pedro, Norma Y., et al.
Publicado: (2013) -
Update and developments in the treatment of glioblastoma multiforme – focus on bevacizumab
por: Wagle, Naveed, et al.
Publicado: (2010) -
Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012) -
A Rare Case of Glioblastoma Multiforme with Osseous Metastases
por: Costa, Rubens Barros, et al.
Publicado: (2017) -
Nanoparticle-Based Treatment in Glioblastoma
por: Roque, Diogo, et al.
Publicado: (2023)